Header Logo

Connection

ARGUN AKCAKANAT to Receptor, Fibroblast Growth Factor, Type 1

Back to Details
This is a "connection" page, showing publications ARGUN AKCAKANAT has written about Receptor, Fibroblast Growth Factor, Type 1.
ARGUN AKCAKANAT
Connection Strength
0.051
Receptor, Fibroblast Growth Factor, Type 1
  1. Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer. Sci Rep. 2023 11 18; 13(1):20223.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.